Article
Supraphysiological androgens suppress prostate cancer growth through androgen receptor–mediated DNA damage
16 Jul 2019
Abstract excerpt
Prostate cancer (PC) is initially dependent on androgen receptor (AR) signaling for survival and growth. Therapeutics designed to suppress AR activity serve as the primary intervention for advanced disease. However, supraphysiological androgen (SPA) concentrations can produce paradoxical responses leading to PC growth inhibition. We sought to discern the mechanisms by which SPA inhibits PC and to determine if...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
